The Centers for Medicare and Medicaid Services (CMS) is updating its rules to encourage states, payers, and Medicare programs to enter value-based payment arrangements (VPA) with drug manufacturers to help reduce drug costs. What does this mean for Medicare providers and beneficiaries?
Are health systems underinvesting in primary care? Do wearables improve health outcomes? What is in the Senate’s drug pricing legislation? Find the answers to these questions and more in The Rundown!
What happened to Trump’s drug pricing proposal? Does downside risk help accountable care organizations? Can the common cold cure some cancers? Find the answers to these questions and more in The Rundown!
Will listing drug prices rein in costs? Is meditation harmful? How does President Trump plan to combat surprise billing? Find the answers to these questions and more in The Rundown!